These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22383943)

  • 21. Molecular characterization of a large cohort of patients with Chronic Granulomatous Disease and identification of novel CYBB mutations: an Italian multicenter study.
    Di Matteo G; Giordani L; Finocchi A; Ventura A; Chiriaco M; Blancato J; Sinibaldi C; Plebani A; Soresina A; Pignata C; Dellepiane RM; Trizzino A; Cossu F; Rondelli R; Rossi P; De Mattia D; Martire B;
    Mol Immunol; 2009 Jun; 46(10):1935-41. PubMed ID: 19410294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exon skipping in CYBB mRNA and skewed inactivation of X chromosome cause late-onset chronic granulomatous disease.
    Eguchi M; Yagi C; Tauchi H; Kobayashi M; Ishii E; Eguchi-Ishimae M
    Pediatr Hematol Oncol; 2018; 35(5-6):341-349. PubMed ID: 30633606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
    Baba LA; Ailal F; El Hafidi N; Hubeau M; Jabot-Hanin F; Benajiba N; Aadam Z; Conti F; Deswarte C; Jeddane L; Aglaguel A; El Maataoui O; Tissent A; Mahraoui C; Najib J; Martinez-Barricarte R; Abel L; Habti N; Saile R; Casanova JL; Bustamante J; Salih Alj H; Bousfiha AA
    J Clin Immunol; 2014 May; 34(4):452-8. PubMed ID: 24596025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De Novo Somatic Mosaicism of CYBB Caused by Intronic LINE-1 Element Insertion Resulting in Chronic Granulomatous Disease.
    Yu L; Li W; Lv G; Sun G; Yang L; Chen J; Zhou L; Ding Y; Zhang Z; Tang X; An Y; Zhao X
    J Clin Immunol; 2023 Jan; 43(1):88-100. PubMed ID: 35997928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 25-kb deletion in the 5' region of the cytochrome b558 heavy chain gene (CYBB) in a patient with X-linked chronic granulomatous disease.
    Faizunnessa NN; Tsuchiya T; Kumatori A; Kurozumi H; Imajoh-Ohmi S; Kanegasaki S; Nakamura M
    Hum Genet; 1997 Apr; 99(4):469-73. PubMed ID: 9099835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CRISPR-Mediated Knockout of Cybb in NSG Mice Establishes a Model of Chronic Granulomatous Disease for Human Stem-Cell Gene Therapy Transplants.
    Sweeney CL; Choi U; Liu C; Koontz S; Ha SK; Malech HL
    Hum Gene Ther; 2017 Jul; 28(7):565-575. PubMed ID: 28264583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematologically important mutations: X-linked chronic granulomatous disease (fourth update).
    Roos D; van Leeuwen K; Hsu AP; Priel DL; Begtrup A; Brandon R; Stasia MJ; Bakri FG; Köker N; Köker MY; Madkaika M; de Boer M; Garcia-Morato MB; Shephard JLV; Roesler J; Kanegane H; Kawai T; Di Matteo G; Shahrooei M; Bustamante J; Rawat A; Vignesh P; Mortaz E; Fayezi A; Cagdas D; Tezcan I; Kitcharoensakkul M; Dinauer MC; Meyts I; Wolach B; Condino-Neto A; Zerbe CS; Holland SM; Malech HL; Gallin JI; Kuhns DB
    Blood Cells Mol Dis; 2021 Sep; 90():102587. PubMed ID: 34175765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
    Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
    BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of 17 new cases of X-linked chronic granulomatous disease with seven novel mutations in the CYBB gene.
    von Goessel H; Hossle JP; Seger R; Gungor T
    Exp Hematol; 2006 Apr; 34(4):528-35. PubMed ID: 16569599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of deletion carriers in X-linked chronic granulomatous disease by real-time PCR.
    Chiriaco M; Di Matteo G; Sinibaldi C; Giardina E; Nardone AM; Folgori L; D'Argenio P; Rossi P; Finocchi A
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):785-9. PubMed ID: 19839755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and biochemical background of chronic granulomatous disease.
    Jurkowska M; Bernatowska E; Bal J
    Arch Immunol Ther Exp (Warsz); 2004; 52(2):113-20. PubMed ID: 15179325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.
    Stasia MJ; Bordigoni P; Floret D; Brion JP; Bost-Bru C; Michel G; Gatel P; Durant-Vital D; Voelckel MA; Li XJ; Guillot M; Maquet E; Martel C; Morel F
    Hum Genet; 2005 Jan; 116(1-2):72-82. PubMed ID: 15538631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked chronic granulomatous disease secondary to skewed X chromosome inactivation in a female with a novel CYBB mutation and late presentation.
    Lewis EM; Singla M; Sergeant S; Koty PP; McPhail LC
    Clin Immunol; 2008 Nov; 129(2):372-80. PubMed ID: 18774749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical, functional and genetic characterization of 16 patients suffering from chronic granulomatous disease variants - identification of 11 novel mutations in CYBB.
    Mollin M; Beaumel S; Vigne B; Brault J; Roux-Buisson N; Rendu J; Barlogis V; Catho G; Dumeril C; Fouyssac F; Monnier D; Gandemer V; Revest M; Brion JP; Bost-Bru C; Jeziorski E; Eitenschenck L; Jarrasse C; Drillon Haus S; Houachée-Chardin M; Hancart M; Michel G; Bertrand Y; Plantaz D; Kelecic J; Traberg R; Kainulainen L; Fauré J; Fieschi F; Stasia MJ
    Clin Exp Immunol; 2021 Feb; 203(2):247-266. PubMed ID: 32954498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.
    Al-Zadjali S; Al-Tamemi S; Elnour I; AlKindi S; Lapoumeroulie C; Al-Maamari S; Pathare A; Dennison D; Krishnamoorthy R
    Clin Genet; 2015 Feb; 87(2):185-9. PubMed ID: 24446915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations of chronic granulomatous disease in Turkish families.
    Köker MY; Sanal O; De Boer M; Tezcan I; Metin A; Ersoy F; Roos D
    Eur J Clin Invest; 2007 Jul; 37(7):589-95. PubMed ID: 17576211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The search for a genetic defect in Polish patients with chronic granulomatous disease.
    Jurkowska M; Kurenko-Deptuch M; Bal J; Roos D
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):441-6. PubMed ID: 15577746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma improves splicing efficiency of CYBB gene transcripts in an interferon-responsive variant of chronic granulomatous disease due to a splice site consensus region mutation.
    Condino-Neto A; Newburger PE
    Blood; 2000 Jun; 95(11):3548-54. PubMed ID: 10828042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel point mutation in the CYBB gene promoter leading to a rare X minus chronic granulomatous disease variant--impact on the microbicidal activity of neutrophils.
    Defendi F; Decleva E; Martel C; Dri P; Stasia MJ
    Biochim Biophys Acta; 2009 Mar; 1792(3):201-10. PubMed ID: 19708127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.